Disclosure 0001193125-26-357383-1

SEC FORM 4

$823.68

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code M) of 429 shares at $1.92 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001193125-26-357383 · filed 2026-08-19 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Artiva Biotherapeutics, Inc. (ARTV)." Disclosed 2026-08-19. https://desqlong.com/cards/0001193125-26-357383-1 (retrieved 2026-09-26).